Medullary Thyroid Cancer Patient's Assessment of Quality of Life Tools: Results from the QaLM Study.

ABSTRACT:

Background

Medullary thyroid cancer (MTC) is a neuroendocrine tumour and a rare variant of thyroid cancer with different aetiology, presentation and treatment to differentiated thyroid cancer. Currently available thyroid cancer-specific quality of life (QoL) tools focus on issues and treatments more relevant to patients with differentiated thyroid cancer and therefore may not address issues specific to a MTC diagnosis and cancer journey.

Method

This prospective multicentre randomised study involved 204 MTC patients completing four quality of life questionnaires (QOLQ) and stating their most and least preferred. The questionnaires were a general instrument, the EORTC QLQ-C30, two disease-specific tools, the MD Anderson Symptom Inventory (MDASI) thyroid module and the City of

SUBMITTER: Moss L 

PROVIDER: S-EPMC7983600 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature